AstraZeneca ditches lung cancer treatment trial

The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.

Black News Black News
Aug 17, 2026 - 08:32
AstraZeneca ditches lung cancer treatment trial
The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.
More Content More Choice